How to Convert a New Device (PMA) into an Old (510(k)) Device: The De Novo 510(k)
Track
:
Track 09: Medical Devices, In Vitro Diagnostics, and Combination Products
Program Code:
312
Date:
Wednesday, June 26, 2013
Time:
8:00 AM to 9:30 AM
EST
Location:
253C
CHAIR
:
Michael A. Swit, Esq, JD (SCHNON), Special Counsel, Duane Morris, LLP, United States
Michael Swit has solved vital FDA legal issues since 1984. Before joining Duane Morris, he was: VP at The Weinberg Group; with 3 major FDA law firms, general counsel of Par Pharmaceutical; and CEO of FDANews.com. He graduated magna cum laude from Bowdoin College and got his law degree at Emory U.
SPEAKER
(S):
Michael A. Swit, Esq, JD (SPKNON), Special Counsel, Duane Morris, LLP, United States
Michael Swit has solved vital FDA legal issues since 1984. Before joining Duane Morris, he was: VP at The Weinberg Group; with 3 major FDA law firms, general counsel of Par Pharmaceutical; and CEO of FDANews.com. He graduated magna cum laude from Bowdoin College and got his law degree at Emory U.
Michael Drues, PhD (SPKNON), Founder and President, Vascular Sciences, United States
Description
Under the 1976 Device Amendments, new technology that is not substantially equivalent to a marketed device is automatically put in Class III. This session reviews how to get that class switched to a less risky, less expensive regulatory path.